ZBTB7A and metastatic neoplasm: After confirming the regulatory role of TMED3 on ZBTB7A in vitro, we further validated ZBTB7A expression in clinical specimens and metastatic tumors through hematoxylin and eosin (H&E) staining and immunofluorescence.